Press Releases (5)
Press Releases
10/27/2021
Immunai Raises $215 Million to Accelerate Development of Its Immune-First Drug Actuary Platform
Press Releases
05/04/2021
Immunai Recognized by Fast Company’s 2021 World Changing Ideas Awards
Press Releases
03/25/2021
Immunai Acquires Dropprint Genomics and Strengthens Leadership Team with Experts in Immunology to Expand Target Discovery Capabilities
Press Releases
02/11/2021
Immunai Raises $60M to Reprogram Immunity – the funding will fuel the growth of Immunai’s proprietary AI-first single-cell drug discovery platform
Press Releases
05/25/2020